Cordis Cardiac & Vascular Institute
CCVI >About CCVI >News

 

Advisory Panel & Faculty
Read More
News
CCVI News
17 May 2010

5th European Interventional Cardiology Fellows Course.

 

11 May 2010

e-Select Registry

 

09 Apr 2010

18-MONTH DATA FROM SORT OUT III TRIAL FAVOURS SIROLIMUS-ELUTING STENTS. Endeavor has higher rates of death, heart attack, and target vessel revascularization.

 

22 Sep 2009

Complex Lesion Workshop Dates confirmed for 2010

 

22 Sep 2009

4th European Interventional Cardiology Fellows Course Awarded 12 CME credits

 

10 Sep 2009

One step ahead in primary PCI: lessons from the STRATEGY, MULTISTRATEGY, TYPHOON and SESAMI trials

 

01 Sep 2009

Transradial approach questionnaire

 

15 Apr 2009

CCVI takes to the road in Belgrade, Serbia

 

08 Apr 2009

NEVO, the Sirolimus Eluting stent: first clinical results and future developments of RES Technology

 

25 Mar 2009

4th European Interventional Cardiology Fellows Course

 

25 Mar 2009

Case Reviews at EuroPCR – focus on patients with diabetes

 

16 Sep 2008

PVD Treatment Milestone Announced at Cardiovascular and Interventional Radiology Society of Europe (Cirse)

 

28 Aug 2008

The CYPHER Sirolimus-eluting Coronary Stent Outperforms the Taxus Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology

 

CCVI News Archive
Published Date
Title
27 Aug 2008
CYPHER SELECT Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks
14 May 2008
Sirolimus-eluting stenting versus balloon angioplasty in patients with infrapopliteal peripheral artery disease
09 Apr 2008
Stenting and surgery comparable for high-risk carotid stenosis patients.
27 Mar 2008
Clinical trial begins for innovative drug-eluting stent with unique reservoir technology
08 Nov 2007
Cordis Europe Signs Agreement with Volcano Europe to Provide Access to State-of-the-Art Intravascular Imaging for Use in Drug-Eluting Stent Procedures

 

This site is published by Cordis Cardiac and Vascular Institute, a division of Johnson & Johnson Medical NV (CCVI), which is solely responsible for the content. It is intended for health care professionals from Europe, Middle-East, Africa and Canada. © CCVI 2011 All rights reserved.
Some documents on this site are stored in Adobe® PDF format and require Adobe® Reader® to view. Click here to download.